Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
A Nexus poll commissioned by BTG Pactual between September 4 and 7 indicates right-wing Senator Flavio Bolsonaro holds a one-point lead over President Luiz Inacio Lula da Silva in a simulated second-round runoff, while first-round voting preferences keep Lula ahead. The survey of 2,002 respondents reports a margin of error of 2 percentage points, m…
Lenovo (LNVGY) combines a broad hardware footprint with fast-growing infrastructure exposure via its ISG and services businesses. At a $52.0B market cap and $83.85 current price, the stock carries a premium multiple but offers asymmetric upside as hyperscale AI and data center demand accelerates. Liquidity and component-cost volatility are real ris…
Pharvaris announced positive topline results from its CHAPTER-3 pivotal Phase 3 trial demonstrating that deucrictibant extended-release (XR) tablet significantly reduces hereditary angioedema (HAE) attacks by 83% compared to placebo. The treatment was well tolerated, met all primary and secondary efficacy endpoints, and provides early and sustained…
Boston Scientific shares dropped 2.3% in pre-market trading after the company notified investors that the cyberattack discovered on August 25 is now expected to have a material impact on third-quarter and full-year 2026 results, and that it is unlikely to meet previously issued net sales growth and adjusted EPS targets. The announcement represents …
HSBC strategist Max Kettner argues that a series of structural changes since 2022 have left risk assets largely impervious to a succession of negative catalysts. He highlights stronger-than-expected earnings, a positive equity-bond correlation, and an expanded central bank toolkit among the main supports for market resilience, while pointing to the…
Bullish, a NYSE-listed global digital asset platform, published its unaudited monthly trading metrics for August 2026 including trading volumes, average trading spreads, and volatility data for Bitcoin and Ethereum. The company also reiterated its comprehensive digital asset infrastructure services and provided context on metrics definitions and da…
BNP Paribas moved Talanx from 'outperform' to 'neutral' following a 23% increase in the insurer's share price since June. The bank reduced its EPS forecasts for 2026 and 2027, set a EUR 120 target price and warned that pricing trends observed in the second quarter could pressure reinsurance combined ratios and commercial top-line growth.
A sudden appreciation of Japan's yen to levels not seen since February disrupted markets at the start of the week, prompting repositioning ahead of what appears to be an impending Bank of Japan rate increase. The move coincided with upgraded Japanese GDP figures and a strong rise in real wages, while gains in other Asian currencies, higher oil and …
Citi Research expects the Bank of Japan to lift its policy rate to 1.25% at the upcoming meeting. Market reaction, the note says, will hinge on the voting behavior of two Policy Board members aligned with Prime Minister Sanae Takaichi, and on the U.S. Federal Reserve’s next interest rate decision. Dissenting votes could reinforce views of political…
Indian equity benchmarks ended lower on Tuesday, with the Nifty 50 slipping 0.61% to a fresh one-month low and the BSE Sensex falling 0.73%. Losses in the Fast Moving Consumer Goods, Healthcare and Oil & Gas sectors outnumbered gains, while market breadth was negative on both exchanges. Commodity and currency moves included weaker gold futures and …
FTC Solar, Inc., a leading provider of solar tracker systems and related services, announced that its management team will attend upcoming investor events including the H.C. Wainwright Global Investment Conference and the TD Cowen Energy Conference. These meetings aim to foster investor relations and provide updates on the company's performance and…
Nova Minerals Corp has received approximately 500 tons of equipment at Port MacKenzie, Alaska, enabling construction of a planned antimony processing and refining facility. This milestone supports the company's goal to establish a secure, fully integrated domestic antimony supply chain, funded by a $43.4 million US Department of War award. Producti…
Bluejay Diagnostics announced a strategic partnership with Lovell Government Services to establish a federal market access and procurement infrastructure, facilitating the commercial introduction of Bluejay's Symphony near-patient diagnostic platform into large U.S. federal healthcare systems such as the VA, DoD, MHS, and IHS following FDA clearanc…
Amazon has quietly become the most diversified play on AI. Between AWS's enterprise compute, Amazon's advertising engine, devices, logistics and consumer flywheel, the company sits at multiple chokepoints where AI will drive incremental revenue and margin expansion. This trade idea lays out a long entry at $165.00 with a $195.00 target and a $150.0…
Goldman Sachs said it is tactically neutral over the coming three months but remains modestly pro-risk across a 12-month horizon. The bank pointed to stronger-than-expected US labor-market data, ongoing procyclical rotations that have slowed since summer, commodity-led returns and a selloff in global sovereign bonds as longer-dated yields climbed. …
Ionis Pharmaceuticals shares plunged in pre-market trading after Novartis disclosed that pelacarsen failed its Phase 3 Lp(a)HORIZON study. Although the drug reduced lipoprotein(a) levels, it did not produce a statistically significant reduction in major cardiovascular events, eliminating the commercial revenue Ionis stood to receive under its 2019 …
Barclays has retained a Neutral rating on the European pharmaceuticals, biotechnology and life sciences sector for 2027 but adopted a more cautious stance compared with its prior positive bias. The bank cited a reduction in expected late-stage pipeline readout potential, marginally slower top-line growth for large-cap names and looming patent expir…
Roivant Sciences stock vaulted in pre-market trading after Pulmovant, a Roivant subsidiary, reported positive topline results from the Phase 2 PHocus trial of mosliciguat for pulmonary hypertension associated with interstitial lung disease. The data were presented at the European Respiratory Society International Congress 2026 by Professor Marc Hum…
Circle sits at the center of the U.S. stablecoin market with $73.3B of USDC in circulation and fresh regulatory advantages. Recent earnings showed improving profitability and higher RLDC margins; technicals are bullish. This is a mid-term swing trade that aims to capture momentum into Arc Mainnet launch and continued USDC adoption, while managing r…
Tesla is spending heavily to pivot from carmaker to mobility-platform owner. The market has punished the stock on execution noise and a disappointing Cybercab event, but the underlying investment in robotaxis and AI could justify a re-rating if milestones materialize. This trade sets a clear entry, stop, and target and treats the idea as a long-ter…
Automatic Data Processing (ADP) offers a pragmatic swing trade: buy around the current price to capture a rebound toward $300 while collecting a safe dividend and riding continued HCM demand. The business generates strong free cash flow, trades at a reasonable P/E for its profile, and benefits from platform-led strategic initiatives like AI tooling…
Ukraine's president said U.S. envoys Steve Witkoff and Jared Kushner brought several "decent ideas" in recent talks with Kyiv and Moscow, but their meetings did not produce a breakthrough to end the war. Zelenskiy signalled further diplomatic work, a planned meeting with U.S. President Donald Trump later in September to discuss winter air defence s…
Biohaven Pharmaceutical shares fell in pre-market trade after RBC Capital downgraded the stock and trimmed its price target, with the move spotlighting valuation concerns and the binary clinical risk tied to the company potekalim epilepsy program ahead of a Phase 3 data readout. The downgrade added selling pressure to a stock that had already poste…
Jefferies upgraded Energean from underperform to hold and increased its price target to 800 pence, pointing to a more attractive risk-reward after the stock underperformed this year despite stronger commodity prices. The broker highlighted the company’s Israel-heavy production mix, updated tax modelling that pushed out Sheshinski levy effects and a…
A bond selloff that accelerated with the war in Iran has pushed the U.S. 10-year Treasury yield close to 5%, a level unseen for sustained periods in almost two decades. Analysts are divided: some view higher yields as evidence of strong demand for capital driven by AI-related spending, while others worry that rising government debt and wider defici…
